[{"address1": "331 Oyster Point Boulevard", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 481 6770", "website": "https://pliantrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Pliant Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases. The company's lead candidate includes bexotegrast, an oral, small-molecule, dual selective inhibitor of av\u00df6 and av\u00df1 integrins, which has completed phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of av\u00df1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins av\u00df8 and av\u00df1 for the treatment of solid tumors; and PLN-101325, a phase 1-ready program for treatment of the muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 171, "companyOfficers": [{"maxAge": 1, "name": "Dr. Bernard  Coulie M.B.A., M.D., Ph.D.", "age": 58, "title": "President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 1078624, "exercisedValue": 0, "unexercisedValue": 4323229}, {"maxAge": 1, "name": "Dr. Keith Lamont Cummings M.B.A., M.D.", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 713074, "exercisedValue": 234570, "unexercisedValue": 1088282}, {"maxAge": 1, "name": "Mr. Johannes P. Hull J.D.", "age": 49, "title": "Chief Business Officer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 654524, "exercisedValue": 0, "unexercisedValue": 1088204}, {"maxAge": 1, "name": "Dr. Eric A. Lefebvre M.D.", "age": 60, "title": "Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 762338, "exercisedValue": 0, "unexercisedValue": 1232340}, {"maxAge": 1, "name": "Dr. Rik  Derynck Ph.D.", "title": "Scientific Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dean  Sheppard M.D.", "title": "Scientific Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bill  DeGrado Ph.D.", "title": "Scientific Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Hal  Chapman M.D.", "title": "Scientific Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Delphine  Imbert Ph.D.", "title": "Chief Technical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher S. Keenan", "title": "Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 7, "compensationRisk": 10, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1756684800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.63, "open": 1.62, "dayLow": 1.61, "dayHigh": 1.89, "regularMarketPreviousClose": 1.63, "regularMarketOpen": 1.62, "regularMarketDayLow": 1.61, "regularMarketDayHigh": 1.89, "payoutRatio": 0.0, "beta": 1.438, "forwardPE": -0.46268657, "volume": 3416685, "regularMarketVolume": 3416685, "averageVolume": 1223732, "averageVolume10days": 901790, "averageDailyVolume10Day": 901790, "bid": 1.83, "ask": 1.9, "bidSize": 1, "askSize": 1, "marketCap": 114182056, "fiftyTwoWeekLow": 1.1, "fiftyTwoWeekHigh": 16.1, "fiftyDayAverage": 1.503, "twoHundredDayAverage": 4.73485, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -88315032, "profitMargins": 0.0, "floatShares": 55572854, "sharesOutstanding": 61388200, "sharesShort": 3318100, "sharesShortPriorMonth": 2877684, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.0541, "heldPercentInsiders": 0.03042, "heldPercentInstitutions": 0.85707, "shortRatio": 2.79, "shortPercentOfFloat": 0.0554, "impliedSharesOutstanding": 61388200, "bookValue": 3.585, "priceToBook": 0.51882845, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -206960992, "trailingEps": -3.38, "forwardEps": -4.02, "enterpriseToEbitda": 0.405, "52WeekChange": -0.85559005, "SandP52WeekChange": 0.18469036, "quoteType": "EQUITY", "currentPrice": 1.86, "targetHighPrice": 4.0, "targetLowPrice": 2.0, "targetMeanPrice": 3.16667, "targetMedianPrice": 3.0, "recommendationMean": 2.72727, "recommendationKey": "hold", "numberOfAnalystOpinions": 6, "totalCash": 262872992, "totalCashPerShare": 4.282, "ebitda": -217976000, "totalDebt": 60376000, "quickRatio": 12.841, "currentRatio": 12.988, "debtToEquity": 27.433, "returnOnAssets": -0.35074002, "returnOnEquity": -0.67550004, "freeCashflow": -111556496, "operatingCashflow": -169402000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PLRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 14.1104, "regularMarketPrice": 1.86, "epsTrailingTwelveMonths": -3.38, "epsForward": -4.02, "epsCurrentYear": -2.8535, "priceEpsCurrentYear": -0.6518311, "fiftyDayAverageChange": 0.357, "fiftyDayAverageChangePercent": 0.23752494, "twoHundredDayAverageChange": -2.8748498, "twoHundredDayAverageChangePercent": -0.6071681, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-06-03", "averageAnalystRating": "2.7 - Hold", "cryptoTradeable": false, "earningsTimestampStart": 1762459200, "earningsTimestampEnd": 1762459200, "isEarningsDateEstimate": true, "corporateActions": [], "postMarketTime": 1757110713, "regularMarketTime": 1757102401, "exchange": "NMS", "messageBoardId": "finmb_325980525", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1591191000000, "postMarketChangePercent": -6.45161, "postMarketPrice": 1.74, "postMarketChange": -0.12, "regularMarketChange": 0.23, "regularMarketDayRange": "1.61 - 1.89", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1223732, "fiftyTwoWeekLowChange": 0.76, "fiftyTwoWeekLowChangePercent": 0.6909091, "fiftyTwoWeekRange": "1.1 - 16.1", "fiftyTwoWeekHighChange": -14.240001, "fiftyTwoWeekHighChangePercent": -0.8844721, "fiftyTwoWeekChangePercent": -85.559006, "shortName": "Pliant Therapeutics, Inc.", "longName": "Pliant Therapeutics, Inc.", "marketState": "CLOSED", "displayName": "Pliant Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-09-06"}]